Diagnostic Aid Offers New Approach to Detecting Early Autism

June 11, 2021 by Alexa Hornbeck
Diagnostic Aid Offers New Approach to Detecting Early Autism
Cognoa's AI-based diagnosis aid works by uniquely collecting and combining inputs from both caregivers/parents and physicians and physicians into a single solution in order to analyze them for predictive autism signals. As part of how the device works, parents or caregivers complete a questionnaire via the Canvas Dx caregiver facing app and upload two short minute videos of their child in their home environment. (Photo courtesy of Cognoa)

The FDA has authorized the first aid for diagnosing Autism Spectrum Disorder in children 18 months through 5 years of age called Canvas Dx. It was developed by Cognoa, a behavioral health company. 

“Currently, pediatricians refer most children with suspected developmental delay to specialists to diagnose and prescribe treatment, which can result in families waiting months or even years before their child receives an initial autism diagnosis and can start potentially life-changing early interventions,” said Dr. Sharief Taraman, division chief at Cognoa.

The senior medical director of Clinical Adoption at Cognoa, Dr. Colleen Kraft, said that one of the reasons primary care physicians often aren’t able to detect autism early is because they have been positioned to identify developmental delay and behavioral conditions, while already managing children with behavioral health conditions such as ADHD, anxiety, and depression. 

Autism spectrum disorder is a complex neurodevelopmental condition that affects communication, learning, and behavior, but there is a lack of established biomarkers for diagnosis. Typically, it is diagnosed by a primary care physician reviewing a child’s behavioral and developmental history and based on a direct observation of symptoms. 

Canvas Dx can give primary care physicians a broader neurodevelopmental picture of a child. It works by having a parent or caregiver complete a questionnaire in the Canvas Dx caregiver-facing app. Two short videos of the child are then uploaded into the app and the videos are reviewed by analysts who complete a questionnaire based on their analysis of the child’s behavior. A doctor then completes a visit and questionnaire with the parent or caregiver and child.

Canvas Dx’s AI algorithm evaluates all the inputs and provides a positive or negative result for autism that the pediatrician utilizes in combination with the clinical presentation of the child to provide a diagnosis and direct appropriate next steps.

“In order to reduce the risk of false classifications, the algorithm has also been designed to provide an indeterminate output as a safety feature. Based on this information and their own clinical evaluation of the child, the doctor will diagnose the child with autism or direct to other next steps in care,” said Taraman.

The diagnostic aid for autism received FDA Breakthrough Device Designation in late 2018, and in 2020 the company completed a study in which the results exceeded the study endpoints and submitted an application for FDA De Novo marketing authorization.

The De Novo premarket review pathway is a regulatory pathway for low-to moderate-risk devices of a new type.

“Along with this authorization, the FDA is establishing special controls for devices of this type, including requirements related to labeling and performance testing,” said Taraman. 

“The marketing authorization of the Cognoa ASD Diagnosis Aid provides a legally marketed device that other sponsors may reference as a predicate device when submitting a 510(k) notification for a device of the same type,” said a spokesperson from the FDA.

While the device has been authorized by the FDA, the agency acknowledged this was done with limitations.

“The risks associated with the use of the device include misdiagnosis and delayed diagnosis of ASD, based on a false positive result, which was observed in 15 out of 303 study subjects without ASD, and a false negative result, which was observed in one out of 122 study subjects with ASD, or when no result was generated. Both misdiagnosis and missed diagnosis can result in delayed treatment of ASD or delivery of treatment not appropriate for ASD,” said the FDA spokesperson. 

Research demonstrates that with autism specific early intervention, children can benefit from greater improvement in cognitive, language, and social skills and decreases in problem behavior and autism symptoms.

The aid may also help to combat diagnostic disparities in detecting ASD. 

A study from the Health Resources and Services Administration shows that children with racial or ethnic minority backgrounds, children from disadvantaged socio-economic backgrounds, and non-native English-speaking children are less likely to be diagnosed with ASD or are diagnosed later than White children. 

While the device will aid in early diagnosis, according to Taraman it will also help primary care physicians avoid biases and disparities existing in the current autism diagnostic process, as most pediatric autism research has focused on White males from an above median socioeconomic background, which isn’t representative of all children. 

In fact, Taraman said that girls are typically diagnosed 1.5 years later than boys, and one in four children under the age of 8 living with autism, most of whom are Black or Hispanic, are not being diagnosed at all. 

“We therefore consciously built our AI algorithm to account for differences in gender, racial, ethnic, and socio-economic backgrounds,” said Taraman. 

While Cognoa doesn’t expect to make Canvas Dx available in the U.S. until later in 2021, the company is working directly with insurers and Medicaid to ensure that Canvas Dx can be reimbursed by health insurance plans.

The company is also developing other solutions as separate products which could potentially use google-glass and AI to further extend the capabilities of the device.

“It is clear that AI has immense potential to make therapeutic solutions more accessible, and available to children with behavioral conditions,” said Taraman.

A+
a-
  • autism
  • Canvas DX
  • Cofnoa
  • diagnostic aid
  • In The News

    Health

    Voting

    Health

    A Year After Jimmy Carter Entered Hospice Care, Advocates Hope His Endurance Drives Awareness

    ATLANTA (AP) — Since Jimmy Carter entered hospice care at his home in south Georgia one year ago, the former U.S. president... Read More

    ATLANTA (AP) — Since Jimmy Carter entered hospice care at his home in south Georgia one year ago, the former U.S. president has celebrated his 99th birthday, enjoyed tributes to his legacy and lost his wife of 77 years. Rosalynn Carter, who died in November, about six months after the Carter... Read More

    February 20, 2024
    by Jesse Zucker
    The Impact of Human Connection on Your Health

    WASHINGTON —  As we trudge through the winter, months of cold and dreary weather may sap our desire to go... Read More

    WASHINGTON —  As we trudge through the winter, months of cold and dreary weather may sap our desire to go outside and socialize. While it’s normal to isolate sometimes, chronic isolation can increase loneliness and be detrimental to your mental and physical health.  Scrolling on social... Read More

    February 20, 2024
    by Jesse Zucker
    Everything You Need to Know About Protein

    WASHINGTON — There is a lot of misinformation in the world of nutrition. Macronutrients and calories get demonized while magical... Read More

    WASHINGTON — There is a lot of misinformation in the world of nutrition. Macronutrients and calories get demonized while magical supplements promise to help you lose weight. Thankfully, protein stays strong throughout all the wild trends — and for good reason. If you’ve ever been told... Read More

    February 14, 2024
    by Dan McCue
    New York City Sues Social Media Platforms for ‘Fueling’ Mental Health Crisis

    NEW YORK — The city of New York and its health and education departments sued five social media platforms on... Read More

    NEW YORK — The city of New York and its health and education departments sued five social media platforms on Wednesday, saying they need to be held accountable for fueling a mental health crisis among youths across the nation. The announcement of the lawsuit against TikTok,... Read More

    February 14, 2024
    by Dan McCue
    COVID Vax, Booster During Pregnancy Bolsters Protections for Newborns

    WASHINGTON — Women who receive an mRNA-based COVID-19 vaccination or booster during pregnancy can provide their infants with significant protection... Read More

    WASHINGTON — Women who receive an mRNA-based COVID-19 vaccination or booster during pregnancy can provide their infants with significant protection against COVID-19 for at least six months after birth, a new study found. The research was conducted by the Infectious Diseases Clinical Research Consortium and published... Read More

    Mental Health Emerges as Dividing Line in Abortion Rights Initiatives Planned for State Ballots

    CHICAGO (AP) — The weeks after Kaniya Harris found out she was pregnant were among the hardest in her life.... Read More

    CHICAGO (AP) — The weeks after Kaniya Harris found out she was pregnant were among the hardest in her life. Final exams were fast approaching for the college junior. Her doctors told her she had an ovarian cyst, and the risk of ectopic pregnancy was high.... Read More

    News From The Well
    scroll top